Search Results 41-50 of 17038 for Plasmacytoma

1. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

   ... plasmacytomas are to have a bone marrow aspirate to obtain tumor cells; biopsy must not be considered to be more than minimal risk to the patient. NOTE ...

2. Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota - Mayo Clinic

   About this study. The purpose of this study is to describe a serial of clustered plasma cell dyscrasia cases in northern Minnesota by describing the disease ...

3. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaped/Refractory Multiple Myeloma - Mayo Clinic

   Criteria for Adverse Events (CTCAE) version 5.0 Grade ≤1. Major Exclusion Criteria: 1. Plasma cell leukemia; non-secretory myeloma (e.g., solitary plasmacytoma)

4. Publications - Mustaqeem A. Siddiqui, M.D., M.B.A. - Mayo Clinic

   Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset. Leukemia. 2018 Jun; 32 (6):1414-1420 Epub 2018 Mar 21. View PubMed ...

5. A Study to Evaluate Lenalidomide and Dexamethasone, with or without Daratumumab, in Treating High-Risk Smoldering Myeloma Patients - Mayo Clinic

   Patient must have no lytic lesions, no known plasmacytoma, and no unexplained hypercalcemia (i.e., > 11 mg/dL or 1mg/dL above ULN). Specifically, local ...

6. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

   ... plasmacytoma at time of enrollment. Lumbar puncture is not required. Patients must not be seropositive for hepatitis C (except in the setting of sustained ...

7. Mayo Clinic Minute: Advances in multiple myeloma treatment VIDEO AUDIO Jason Multiple myeloma is a cancer that forms in a type o

   Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell that builds up in bone marrow. 02:25. Joselle Cook, M.B.B.S..

8. Monoclonal Proteins by Blood Spot and Saliva - Mayo Clinic

   The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

9. Clinical Trials - AHEAD Plasma Extension Study

   About this study. The purpose of this study is to collect longitudinal cognitive and functional assessments and blood-based biomarker data.

10. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

    Measurable plasmacytoma; Monoclonal plasma cells in bone marrow. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2, or 3; Absolute ...